ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Interim, IR, Listing Regulation, News, Regulatory, Report, Swedish, Yearend
November 18, 2024
15 Feb 2024

Acarix AB (publ) publicerar Bokslutskommuniké 2023

Fokus mot USA och hållbar tillväxtSom nyutnämnd VD är jag hedrad att få leda Acarix och dela en del av v&ari...
Continue reading
author-avatar acarix
English, Interim, IR, Listing Regulation, News, Regulatory, Report, Yearend
November 18, 2024
15 Feb 2024

Acarix AB (publ) publishes Year-End Report 2023

Embarking on a new journey with focus on sustainable growthAs the newly appointed CEO of Acarix, I am honored to be on board and share ...
Continue reading
author-avatar acarix
Corporate Information, English, General meeting, IR, Listing Regulation, News, Notice, Regulatory
November 18, 2024
01 Feb 2024

NOTICE OF EXTRA GENERAL MEETING IN ACARIX AB

The shareholders of Acarix AB, reg. no. 559009-0667 (the "Company"), are hereby invited to the extra general meeting on Wednesday 21 Fe...
Continue reading
author-avatar acarix
Corporate Information, General meeting, IR, Listing Regulation, News, Notice, Regulatory, Swedish
November 18, 2024
01 Feb 2024

KALLELSE TILL EXTRA BOLAGSSTÄMMA I ACARIX AB

Aktieägarna i Acarix AB, org.nr 559009-0667 ("Bolaget"), kallas härmed till extra bolagsstämma onsdagen den 21 februari ...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Issuance, MAR, mfn-cus-disclaimer, News, Regulatory, Shares
November 18, 2024
01 Feb 2024

Acarix carries out a directed share issue of approximately SEK 33.7 million

THIS PRESS RELEASE IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BE...
Continue reading
author-avatar acarix
Corporate Action, IR, Issuance, MAR, mfn-cus-disclaimer, News, Regulatory, Shares, Swedish
November 18, 2024
01 Feb 2024

Acarix genomför en riktad emission om cirka 33,7 MSEK

DETTA PRESSMEDDELANDE ÄR EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARKEN DIREKT ELLER INDIREKT, INOM ELL...
Continue reading
author-avatar acarix
Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory
November 18, 2024
01 Feb 2024

Acarix appoints Aamir Mahmood as new CEO

Stockholm, Sweden, Feb 1, 2024 - The Board of Acarix AB (publ) announces today the appointment of Aamir Mahmood as new CEO with immedia...
Continue reading
author-avatar acarix
Corporate Information, IR, MAR, News, Other Corporate Information, Regulatory, Swedish
November 18, 2024
01 Feb 2024

Acarix utser Aamir Mahmood till ny VD

Stockholm, Sverige, 1 februari 2024 - Styrelsen för Acarix AB tillkännager idag att Aamir Mahmood utsetts till ny VD och till...
Continue reading
author-avatar acarix
Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory
November 18, 2024
30 Nov 2023

Acarix changes Certified Adviser to Carnegie Investment Bank AB (publ)

Acarix, a leader in advanced acoustic-based cardiac diagnostics, today announces a change of Certified Adviser from Erik Penser Bank AB...
Continue reading
author-avatar acarix
Corporate Information, IR, Listing Regulation, News, Other Corporate Information, Regulatory, Swedish
November 18, 2024
30 Nov 2023

Acarix byter Certified Adviser till Carnegie Investment Bank AB (publ)

Acarix, ledande inom avancerad akustisk hjärtdiagnostik, meddelar idag att man byter Certified Adviser från Erik Penser Bank...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Issuance, Listing Regulation, News, Regulatory, Shares
November 18, 2024
16 Nov 2023

ACARIX CARRIES OUT A DIRECTED ISSUE TO GUARANTORS FOLLOWING THE COMPLETED RIGHTS ISSUE

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, HONG ...
Continue reading
author-avatar acarix
Corporate Action, IR, Issuance, Listing Regulation, News, Regulatory, Shares, Swedish
November 18, 2024
16 Nov 2023

ACARIX GENOMFÖR RIKTAD NYEMISSION TILL GARANTER EFTER DEN GENOMFÖRDA FÖRETRÄDESEMISSIONEN

EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARE SIG DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AUSTRALIEN, BEL...
Continue reading
  • «
  • ‹
  • 2
  • 3
  • 4
  • 5
  • 6
  • ›
  • »

Acarix AB

Jungmansgatan 12
211 19 Malmö
SE
info@acarix.com

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V6

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.